What Is the “Series A Crunch” and How to Survive It
The startup world moves fast, but one roadblock has stalled countless promising companies: the Series A Crunch. Founders talk about it with dread, investors treat it as a filter, and…
Your Gateway to Entrepreneurial Universe
The startup world moves fast, but one roadblock has stalled countless promising companies: the Series A Crunch. Founders talk about it with dread, investors treat it as a filter, and…
Founders in every startup ecosystem share one rumor: somewhere, a “blacklist” of entrepreneurs exists that venture capitalists quietly circulate. According to the whispers, once your name lands on that list,…
Venture capital looks glamorous. Founders see headlines about huge funding rounds and billion-dollar valuations. Social media celebrates every startup that lands a big check. Many entrepreneurs assume VC money equals…
Entrepreneurs often launch startups in the open. They talk about their ideas on social media. They share updates in newsletters. They announce partnerships and new hires. Yet some founders choose…
Zepto officially launched Zepto Pharmacy, a 10-minute medicine delivery service, in select areas of Mumbai, Bengaluru, Delhi NCR, and Hyderabad. CEO and Co-founder Aadit Palicha announced the expansion on Thursday…
On August 7, 2025, OpenAI announced the launch of GPT-5, the company’s most advanced large language model so far. The company made GPT-5 available to everyone, including free-tier ChatGPT users,…
Japanese food tech company Kinish has unveiled a new plant-based ice cream brand that puts rice in the spotlight. Called The Rice Creamery, the range ditches dairy and focuses on…
Meta Platforms acquired WaveForms AI, a startup that specialises in detecting and replicating emotion in audio using artificial intelligence. This acquisition marks a major step in Meta’s plan to develop…
Reliance Retail took a decisive step in 2025 when it wrote off its entire ₹1,645 crore investment in Dunzo. That equals about USD 200 million. The move counts as one…
Sanofi took a bold step in the neuroscience sector on August 6, 2025, by acquiring Vigil Neuroscience, a U.S.-based biotechnology company. This acquisition aligns with Sanofi’s strategy to build a…